Sonokine Biosciences


Launched:

2022

Management:

Herbert Kim Lyerly

Duke Inventor(s):

Herbert Kim Lyerly, Zach Hartman, Takuya Osada

 

 

 

 

 

 

Sonokine Biosciences is developing cancer treatments that use high intensity focused ultrasound in combination with targeted delivery of immune therapies.